NCT00734708 - Phase 3 Clinical Trial of Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2(Trafermin) | Biotech Hunter

Enrollment

328

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

March 31, 2010

Conditions

PeriodontitisAlveolar Bone LossPeriodontal Attachment Loss

Interventions

DRUG

Trafermin (genetical recombination)

Administered to the bone defect during flap operation

DRUG

Placebo

Control

Trial Locations (21)

Kaken Investigational Site, Nagoya

Kaken Investigational Site, Matsudo

Kaken Investigational Site, Fukuoka

Kaken Investigational Site, Kitakyushu

Kaken Investigational Site, Hiroshima

Kaken Investigational Site, Ishikari-Tobetsu

Kaken Investigational Site, Sapporo

Kaken Investigational Site, Morioka

Kaken Investigational Site, Kagoshima

Kaken Investigational Site, Machida

Kaken Investigational Site, Yokohama

Kaken Investigational Site, Sendai

Kaken Investigational Site, Nagasaki

Kaken Investigational Site, Niigata

Kaken Investigational Site, Okayama

Kaken Investigational Site, Suita

Kaken Investigational Site, Tokushima

Kaken Investigational Site, Bunkyo-ku

Kaken Investigational Site, Chiyoda-ku

Kaken Investigational Site, Ōta-ku

Kaken Investigational Site, Sinjyuku-ku